eli lilly glp 1 mounjaro endowment stock soars on encouraging results for daily weight-loss pill Eli Lilly could launch obesity
Description
Insurers raised cost-sharing sharply for GLP-1s in recent years and also increased use of prior authorization.
That doesnt make GLP-1s good or bad
The rapid global adoption of GLP-1 based therapies, developed for diabetes and now also used for weight management, has reshaped the pharma landscape
Coverage of the drugs for weight loss would end on Oct
Nourish oral microbiome, digestive, and gut health with Boost Synergy GLP-1 Probiotic featuring Akkermansia muciniphila
